deflazacort
deflazacort is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand names including Deflazacort, DEFLAZACORT, EMFLAZA. Available dosage forms: tablet, suspension.
Drug Details
- Generic Name
- deflazacort
- Brand Names
- Deflazacort, DEFLAZACORT, EMFLAZA, PYQUVI
- Application Number
- ANDA217173
- Sponsor
- Amneal Pharmaceuticals NY LLC
- NDC Codes
- 10
- Dosage Forms
- TABLET, SUSPENSION
- Routes
- ORAL
- Active Ingredients
- DEFLAZACORT
Indications and Usage
1 INDICATIONS AND USAGE Deflazacort oral suspension is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older. Additional pediatric use information is approved for PTC Therapeutics, Inc.'s Emflaza™ (deflazacort) oral suspension. However, due to PTC Therapeutics, Inc.'s marketing exclusivity rights, this drug product is not labeled with that information . Deflazacort oral suspension is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older ( 1 )